Measuring and improving the quality of home care

Published Date: 13 Mar 2023

This document outlines goals for improving the quality of care in nursing homes and provides recommendations to support these efforts.

Read Full News

Latest News

Sunscreen Myths: How Evidence Morphed Into Skepticism

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

How to Mange Benign Prostatic Hypertrophy in Primary Care

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

For Everyday Shoulder Pain, Less Treatment Is Often More

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

Regular Physical Exercise Tied to Lower Mental Disorder Risk

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Hormonal Contraception Not Linked to Flare Risk in UC

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

Are Pediatricians Following Newborn Jaundice Guidelines?

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Arturo Loaiza-Bonilla, MD, MSEd, explores how confusing and incomplete information on sunscreen safety can lead to misinterpretation and misinformation.

Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy.

Most patients with a nontraumatic sore shoulder in primary care can be managed with watchful waiting and symptom relief.

A prospective study shows that lower levels of physical exercise are consistently associated with a higher risk for common mental disorders in students pursuing higher education.

Exposure to hormonal contraception is not linked to an increased risk for recurrent flares or cumulative systemic inflammatory burden in female individuals with ulcerative colitis.

The American Academy of Pediatrics changed its guidelines in 2022, but a new study suggests pediatricians may not be consistently applying the updated guidance.

News All Time

Menopausal Hormone Therapy May Cut Costs, Improve Health

An analysis finds that menopausal hormone therapy could save thousands of dollars per patient while improving quality of life and reducing cardiovascular disease and deaths.

Real-Life Walking Speed Can Track MS Progression

Wearable accelerometer-based real-life walking speed monitoring can track disability progression earlier and more often than conventional tests in primary progressive multiple sclerosis.

Autism Prevalence Rising Among School-Aged Kids in England

The prevalence of autism continues to rise among school-aged children and young people in England, an analysis of data from 2016 to 2024 shows.

Cannabis Use Linked to Earlier Psychosis Onset

Cannabis users experience psychosis onset 2.5 years earlier on average compared with non-users, a meta-analysis shows.

Radiation in Pancreatic Cancer: ASTRO Updates Its Guidance

The new guidance strengthens radiation therapy recommendations in pancreatic cancer, providing an update to the 2019 guidance.

How Primary Care Physicians Can Support Addiction Recovery

Rural clinicians provide addiction care despite limited services, long travel distances, and gaps in treatment access that can make ongoing support difficult for patients.

Vaccines Saved Millions: The Success That Became Invisible

Declining vaccination coverage and rapidly spreading misinformation contribute to renewed outbreaks of diseases once controlled through widespread immunization.

Physical Activity and Dementia: A Work-Leisure Divide

Staying active during leisure time is linked to a lower risk for dementia, whereas physical activity on the job showed the opposite pattern.

County-Level Medical Debt Tied to Poorer Cancer Survival

Americans living in areas mired in medical debt have later cancer diagnoses and lower survival rates.

HTTP error: 503HTTP error: 503

Fostemsavir Shows Promise in Multidrug-Resistant HIV

Fostemsavir is associated with maintained viral suppression in many heavily treated patients with multidrug-resistant HIV.

HTTP error: 503HTTP error: 503

ESC 2026: Clinical Trials That Could Change Practice

Which ESC 2026 trials matter most? An expert preview singles out the studies most likely to open new therapeutic avenues or challenge current practice.

Microbiome ‘Leak’ From Mouth to Gut Can Flag GI Cancer

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal cancers with greater accuracy than conventional stool testing.

Measuring and improving the quality of home care

Latest News

Sunscreen Myths: How Evidence Morphed Into Skepticism

How to Mange Benign Prostatic Hypertrophy in Primary Care

For Everyday Shoulder Pain, Less Treatment Is Often More

Regular Physical Exercise Tied to Lower Mental Disorder Risk

Hormonal Contraception Not Linked to Flare Risk in UC

Are Pediatricians Following Newborn Jaundice Guidelines?

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Phase 3 Eplontersen Trial Results Disappoint

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Phase 3 Eplontersen Trial Results Disappoint

Latest News

News All Time

Menopausal Hormone Therapy May Cut Costs, Improve Health

Real-Life Walking Speed Can Track MS Progression

Autism Prevalence Rising Among School-Aged Kids in England

Cannabis Use Linked to Earlier Psychosis Onset

Radiation in Pancreatic Cancer: ASTRO Updates Its Guidance

How Primary Care Physicians Can Support Addiction Recovery

Vaccines Saved Millions: The Success That Became Invisible

Physical Activity and Dementia: A Work-Leisure Divide

County-Level Medical Debt Tied to Poorer Cancer Survival

Fostemsavir Shows Promise in Multidrug-Resistant HIV

ESC 2026: Clinical Trials That Could Change Practice

Microbiome ‘Leak’ From Mouth to Gut Can Flag GI Cancer

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.